Back to Search
Start Over
4'-O-methylbavachalcone alleviates ischemic stroke injury by inhibiting parthanatos and promoting SIRT3.
- Source :
-
European journal of pharmacology [Eur J Pharmacol] 2024 Jun 05; Vol. 972, pp. 176557. Date of Electronic Publication: 2024 Apr 03. - Publication Year :
- 2024
-
Abstract
- Cerebral ischemia-reperfusion injury (CIRI) can induce massive death of ischemic penumbra neurons via oxygen burst, exacerbating brain damage. Parthanatos is a form of caspase-independent cell death involving excessive activation of PARP-1, closely associated with intense oxidative stress following CIRI. 4'-O-methylbavachalcone (MeBavaC), an isoprenylated chalcone component in Fructus Psoraleae, has potential neuroprotective effects. This study primarily investigates whether MeBavaC can act on SIRT3 to alleviate parthanatos of ischemic penumbra neurons induced by CIRI. MeBavaC was oral gavaged to the middle cerebral artery occlusion-reperfusion (MCAO/R) rats after occlusion. The effects of MeBavaC on cerebral injury were detected by the neurological deficit score and cerebral infarct volume. In vitro, PC-12 cells were subjected to oxygen and glucose deprivation/reoxygenation (OGD/R), and assessed cell viability and cell injury. Also, the levels of ROS, mitochondrial membrane potential (MMP), and intracellular Ca <superscript>2+</superscript> levels were detected to reflect mitochondrial function. We conducted western blotting analyses of proteins involved in parthanatos and related signaling pathways. Finally, the exact mechanism between the neuroprotection of MeBavaC and parthanatos was explored. Our results indicate that MeBavaC reduces the cerebral infarct volume and neurological deficit scores in MCAO/R rats, and inhibits the decreased viability of PC-12 cells induced by OGD/R. MeBavaC also downregulates the expression of parthanatos-related death proteins PARP-1, PAR, and AIF. However, this inhibitory effect is weakened after the use of a SIRT3 inhibitor. In conclusion, the protective effect of MeBavaC against CIRI may be achieved by inhibiting parthanatos of ischemic penumbra neurons through the SIRT3-PARP-1 axis.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Rats
Male
Ischemic Stroke drug therapy
Ischemic Stroke pathology
Ischemic Stroke metabolism
Reactive Oxygen Species metabolism
PC12 Cells
Membrane Potential, Mitochondrial drug effects
Neurons drug effects
Neurons pathology
Neurons metabolism
Calcium metabolism
Infarction, Middle Cerebral Artery drug therapy
Infarction, Middle Cerebral Artery pathology
Infarction, Middle Cerebral Artery complications
Cell Survival drug effects
Sirtuin 3 metabolism
Sirtuin 3 genetics
Poly (ADP-Ribose) Polymerase-1 metabolism
Poly (ADP-Ribose) Polymerase-1 antagonists & inhibitors
Mitochondria drug effects
Mitochondria metabolism
Chalcones pharmacology
Chalcones therapeutic use
Rats, Sprague-Dawley
Neuroprotective Agents pharmacology
Neuroprotective Agents therapeutic use
Reperfusion Injury drug therapy
Reperfusion Injury pathology
Reperfusion Injury metabolism
Parthanatos drug effects
Sirtuins
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0712
- Volume :
- 972
- Database :
- MEDLINE
- Journal :
- European journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 38574839
- Full Text :
- https://doi.org/10.1016/j.ejphar.2024.176557